4.6 Article

An off-the-shelf decellularized and sterilized human bone-ACL-bone allograft for anterior cruciate ligament reconstruction

出版社

ELSEVIER
DOI: 10.1016/j.jmbbm.2022.105452

关键词

ACL; Anterior cruciate ligament; ACL Reconstruction; Allograft; Decellularization; Supercritical carbon dioxide sterilization

资金

  1. Dutch Research Council (NWO) [17734]
  2. NWO [17734]
  3. European Union's Horizon 2020 research and innovation programme [952981]

向作者/读者索取更多资源

This study proposes the use of decellularized bone-ACL-bone allografts as an alternative to autografts in ACL reconstruction. The results show that the decellularized allografts have similar mechanical properties to the native ACL, maintain similar collagen content, and do not cause cytotoxicity to tendon-derived cells.
Approximately 1% of active individuals participating in sports rupture their anterior cruciate ligaments (ACL) every year, which is currently reconstructed using tendon autografts. Upon reconstruction, clinical issues of concern are ACL graft rupture, persistent knee instability, limited return to sports, and early onset of osteoar-thritis (OA). This happens because tendon autografts do not have the same compositional, structural, and me-chanical properties as a native ACL. To overcome these problems, we propose to use decellularized bone-ACL-bone allografts in ACL reconstruction (ACLR) as a mechanically robust, biocompatible, and immunologically safe alternative to autografts. Here, a decellularization protocol combined with sterilization using supercritical carbon dioxide (scCO2) was used to thoroughly decellularize porcine and human ACLs attached to tibial and femoral bone blocks. The specimens were named ultrACLean and their compositional, structural, and mechanical properties were determined. Our results indicate that: 1) decellularization of ultrACLean allografts leads to the removal of nearly 97% of donor cells, 2) ultrACLean has mechanical properties which are not different to native ACL, 3) ultrACLean maintained similar collagen content and decreased GAG content compared to native ACL, and 4) ultrACLean is not cytotoxic to seeded tendon-derived cells in vitro. Results from an in vivo pilot experiment showed that ultrACLean is biocompatible and elicits a moderate immunological response. In summary, ultrA-CLean has proven to be a mechanically competent and biocompatible graft with the potential to be used in ACLR surgery.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据